Expertise in
21
conditions

Matthew C. Kiernan

139 Barker Street, 
Randwick, NSW, AU 
Expertise in
21
conditions
139 Barker Street, 
Randwick, NSW, AU 
OverviewLocationsClinical Research

Overview

Matthew Kiernan practices in Randwick, Australia. Mr. Kiernan is highly rated in 21 conditions, according to our data. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Frontotemporal Dementia, Peripheral Neuropathy, and Gastrostomy.

His clinical research consists of co-authoring 559 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

139 Barker Street, Randwick, NSW 2031, Australia
Other Locations
Western Sydney Local Health District
Sydney, NSW 2145, Australia
94 Mallett Street, Sydney, NSW 2050, Australia
Barker Street, Sydney, NSW 2031, Australia
Barker St, Randwick, NSW 2031, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Randomised Double-Blind Placebo-Controlled Phase 3 Trial of Triumeq in Amyotrophic Lateral Sclerosis
Randomised Double-Blind Placebo-Controlled Phase 3 Trial of Triumeq in Amyotrophic Lateral Sclerosis
Enrollment Status: Terminated
Publish Date: July 11, 2025
Intervention Type: Drug
Study Drug: Dolutegravir, Abacavir and Lamivudine
Study Phase: Phase 3
Phase 2a Open Label Study, Safety and Tolerability of Combination Antiretroviral Therapy (Triumeq) in Participants With Amyotrophic Lateral Sclerosis (ALS) - The Lighthouse Project.
Phase 2a Open Label Study, Safety and Tolerability of Combination Antiretroviral Therapy (Triumeq) in Participants With Amyotrophic Lateral Sclerosis (ALS) - The Lighthouse Project.
Enrollment Status: Completed
Publish Date: August 22, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

559 Total Publications

Behavioral subtypes impact prognosis and survival in amyotrophic lateral sclerosis: a clustering-based approach.
Behavioral subtypes impact prognosis and survival in amyotrophic lateral sclerosis: a clustering-based approach.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: August 21, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kiernan's expertise for a condition
ConditionClose
View All 9 Distinguished Conditions
View All 10 Advanced Conditions
View All 58 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile